首页> 外文OA文献 >PCN189 Pharmacoeconomic Evaluation Of The Use Of Trastuzumab For Subcutaneous Administration Compared To Intravenous Dosage Form In The Treatment Of Breast Cancer

【2h】

PCN189 Pharmacoeconomic Evaluation Of The Use Of Trastuzumab For Subcutaneous Administration Compared To Intravenous Dosage Form In The Treatment Of Breast Cancer

机译：PCN189曲妥珠单抗皮下给药与静脉内给药形式比较在乳腺癌治疗中的药物经济学评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kulikov A; Rybchenko Y;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Subcutaneous trastuzumab (Herceptin) versus intravenous trastuzumab for the treatment of patients with HER2-positive breast cancer: A time, motion and cost assessment study in a lean operating day care oncology unit [J] . Wiebren A.A. Tjalma, Tom Van den Mooter, Tim Mertens, European Journal of Obstetrics, Gynecology and Reproductive Biology: An International Journal . 2018,第期

机译：皮下曲据（Herceptin）与静脉内曲妥珠单抗治疗Her2阳性乳腺癌的患者：瘦营运日保健肿瘤学单位的时间，运动和成本评估研究
2. Subcutaneous Trastuzumab (Herceptin?): A UK Time and Motion Study in Comparison with Intravenous Formulation for the Treatment of Patients with HER2-Positive Early Breast Cancer [J] . Russell Burcombe, Steve Chan, Richard Simcock, Advances in Breast Cancer Research . 2013,第4期

机译：皮下曲妥珠单抗（赫赛汀（Herceptin？））：英国时间和运动研究与静脉内制剂治疗HER2阳性早期乳腺癌患者的比较
3. Costs of subcutaneous and intravenous administration of trastuzumab for patients with HER2-positive breast cancer [J] . Olsen Jens, Jensen Kenneth Forsstrom, Olesen Daniel Sloth, Journal of comparative effectiveness research . 2018,第5期

机译：皮下和静脉施用曲妥珠单抗治疗患者患者2患者
4. Detection of tumour containing sentinel lymph node in breast cancer by injection of fluorescence tracer through ¿¿¿dual route¿¿¿ in breast tissue and intravenously [C] . Darakhshan Qaiser, Anurag Srivastava, D. S Mehta, International Conference on Photonics, Optics and Laser Technology . 2015

机译：通过在乳房组织中和静脉内通过双向注射荧光示踪剂检测乳腺癌中含有前哨淋巴结的肿瘤
5. Impact of HER-2/neu detection by fluorescence in situ hybridization (FISH) on trastuzumab therapy in the treatment of metastatic breast cancer. [D] . Subongkot, Suphat. 2003

机译：荧光原位杂交（FISH）检测HER-2 / neu对曲妥珠单抗治疗转移性乳腺癌的影响。
6. Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer [O] . Luis Rojas, Sabrina Muñiz, Lidia Medina, 2020

机译：智利HER2阳性早期乳腺癌患者皮下或静脉曲妥珠单抗给药的成本最小化分析
7. PCN75 - BUDGET IMPACT MODEL OF SUBCUTANEOUS TRASTUZUMAB COMPARED WITH INTRAVENOUS TRASTUZUMAB ON THE TREATMENT OF HER-2 POSITIVE BREAST CANCER IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM [O] . D. Kashiura, P.V. Souza, S.D. Garrido, 2018

机译：皮下曲妥珠单抗与静脉曲造珠内菌与静脉胸瘤患者对巴西私人医疗保健系统治疗胸腺胸癌的预算影响模型

PCN189 Pharmacoeconomic Evaluation Of The Use Of Trastuzumab For Subcutaneous Administration Compared To Intravenous Dosage Form In The Treatment Of Breast Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅